EVOQ Remedies Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

2.85 -0.15 (-5.00%)Updated : 05 Dec 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	14.04	5.70	24.13	15.32
Net Income After Taxes	0.09	0.45	1.62	1.09
Income Availableto Com Incl Extra Ord	0.09	0.45	1.62	1.09
Costof Revenue Total	13.08	1.56	19.33	13.77
Other Net	2.41	2.26	6.02	0.00
Gross Profit	-1.32	2.50	1.06	3.01
Diluted Weighted Average Shares	2.49	1.36	1.36	1.36
Diluted Net Income	0.09	0.45	1.62	1.09
Provisionfor Income Taxes	0.04	0.16	0.67	0.37
Depreciation/ Amortization	0.05	0.01	0.00	0.00
period Type	-	-	-	-
Net Income Before Extra Items	0.09	0.45	1.62	1.09
Total Revenue	11.76	4.05	20.39	16.78
Operating Income	-2.29	-1.65	-3.74	1.46
Net Income	0.09	0.45	1.62	1.09
period Length	12.00	12.00	12.00	12.00
Revenue	11.76	4.05	20.39	16.78
Income Availableto Com Excl Extra Ord	0.09	0.45	1.62	1.09
Selling/ General/ Admin Expenses Total	0.07	0.08	0.20	0.18
Other Operating Expenses Total	0.84	4.06	4.59	1.37
Net Income Before Taxes	0.13	0.61	2.28	1.46
Diluted Normalized EPS	0.04	0.33	1.19	0.80
Diluted EPS Excluding Extra Ord Items	0.04	0.33	1.19	0.80
Total Adjustmentsto Net Income	-	-	-	0.00
Interest Inc( Exp) Net- Non- Op Total	-	-	-	0.00
DPS- Common Stock Primary Issue	-	-	-	0.00